The global rapid hepatitis testing market is set to make significant strides, with an estimated valuation of USD 3.2 billion in 2023, projected to escalate to USD 4.9 billion by 2033. This growth represents a robust compound annual growth rate (CAGR) of 4.4% over the forecast period, underscoring the increasing urgency for effective hepatitis diagnostics …